MedPath
NMPA Approval

Dactinomycin for Injection

国药准字H31021714

July 20, 2020

Drug Information

注射用放线菌素D

注射剂

0.2mg(按C62H86N12O16计)

化学药品

July 20, 2020

Company Information

Applicant Company

Manufacturing Company

上海市浦东新区川沙路978号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用放线菌素D - NMPA 批准文号 | MedPath